Dermapharm Holding SE (LON: 0A5J)
London flag London · Delayed Price · Currency is GBP · Price in EUR
39.92
-0.38 (-0.95%)
At close: Jan 21, 2025

Dermapharm Holding SE Company Description

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany.

The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts.

It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals.

The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology.

In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand.

It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo brands.

The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.

Dermapharm Holding SE
Country Germany
Founded 1991
Industry Pharmaceutical Preparations
Employees 3,497
CEO Hans-Georg Feldmeier

Contact Details

Address:
Lil-Dagover-Ring 7
Grünwald, 82031
Germany
Phone 49 89 6 41 86 0
Website ir.dermapharm.de

Stock Details

Ticker Symbol 0A5J
Exchange London Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 2834

Key Executives

Name Position
Hans-Georg Feldmeier Chief Executive Officer
Christof Dreibholz Chief Financial Officer
Britta Hamberger Head of Investor Relations